Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study
Authors
Keywords
-
Journal
ACTA DIABETOLOGICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-03
DOI
10.1007/s00592-021-01841-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease
- (2021) Xiaomeng Feng et al. BMC Endocrine Disorders
- Metformin Is Associated with a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared to Sulfonylureas: An Observational Study
- (2021) Anna Ostropolets et al. Circulation-Arrhythmia and Electrophysiology
- Metformin accelerates zebrafish heart regeneration by inducing autophagy
- (2021) Fangjing Xie et al. npj Regenerative Medicine
- Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis
- (2021) Jonathan V. Mui et al. Frontiers in Cardiovascular Medicine
- Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study
- (2020) Shilan Seyed Ahmadi et al. Cardiovascular Diabetology
- A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study
- (2020) Reid H. Whitlock et al. MAYO CLINIC PROCEEDINGS
- Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus
- (2020) Eun-Hee Cho et al. MEDICINE
- Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study
- (2019) Alexander Zabala et al. DIABETES OBESITY & METABOLISM
- Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
- (2019) Rishi J Desai et al. BMJ-British Medical Journal
- All-cause mortality in patients on sulphonylurea monotherapy compared to metformin monotherapy in a nation-wide cohort
- (2018) Sascha Reiff et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
- (2017) Ariela R. Orkaby et al. NEUROLOGY
- Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence
- (2017) Charles E. Leonard et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
- (2017) Christianne L. Roumie et al. Journal of the American Heart Association
- Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes
- (2016) Suetonia C. Palmer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014
- (2016) Diana Hedevang Christensen et al. Clinical Epidemiology
- Neuropharmacological Actions of Metformin in Stroke
- (2015) Jia Jia et al. Current Neuropharmacology
- Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans
- (2015) Nino G. Joy et al. DIABETES
- Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China
- (2015) Lihua Zhang et al. Diabetes Technology & Therapeutics
- Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke
- (2014) Qin Jin et al. BRAIN BEHAVIOR AND IMMUNITY
- 7. Approaches to Glycemic Treatment
- (2014) DIABETES CARE
- Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia
- (2014) Ghorbangol Ashabi et al. METABOLIC BRAIN DISEASE
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
- (2013) Francesco Paneni et al. EUROPEAN HEART JOURNAL
- Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control
- (2013) Adriana M. Hung et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation
- (2011) Rachel R. Huxley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Insulin receptor and cancer
- (2011) A. Belfiore et al. ENDOCRINE-RELATED CANCER
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
- (2011) S. Singh et al. THORAX
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
- (2009) Laleh Razavi Nematollahi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metabolic Syndrome and Risk of Development of Atrial Fibrillation
- (2008) Hiroshi Watanabe et al. CIRCULATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started